Company news

Rakovina Therapeutics Inc news in 2021

Rakovina Therapeutics Inc's news releases, calls and decks from 2021, newest first.

View company

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

December 20, 2021

InvestmentPitch Media Video Discusses Rakovina Therapeutics' Partnership with St. Baldrick's Foundation to Research and Develop New Treatments for Childhood Bone Cancer - Video Available on Investmentpitch.com

November 17, 2021

InvestmentPitch Media Video Discusses Rakovina Therapeutics' Receipt of Notice of Allowance for New U.S. Patent Covering kt-2000 Series PARP Inhibitors - Video Available on Investmentpitch.com

October 8, 2021

Rakovina Therapeutics to Present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

August 17, 2021

Red Thread Ventures' portfolio company Rakovina Therapeutics'

August 11, 2021

Rakovina Therapeutics Announces Results from Annual General Meeting

June 29, 2021

Rakovina Therapeutics to Present at at The Emerging Growth Conference on June 23, 2021

June 17, 2021

Rakovina Therapeutics Inc. Announces First Quarter 2021 Financial Results and Provides Corporate Update

May 27, 2021

Rakovina Therapeutics Inc. Announces Inaugural Scientific Advisory Board

April 29, 2021

Rakovina Therapeutics Inc. Receives European and Canadian Patents on kt-2000 series PARP-inhibitors

April 8, 2021

Rakovina Therapeutics Inc. Appoints Biotechnology Industry Veteran Julie M. Cherrington, PhD to Board of Directors

April 5, 2021

InvestmentPitch Media Video Discusses Newly Listed Rakovina Therapeutics, a Developer of New Cancer Treatments Targeting Critical DNA Damage Response Mutations - Video Available on Investmentpitch.com

April 5, 2021

Rakovina Therapeutics Inc. Commences Trading on TSX Venture Exchange Under Ticker Symbol "RKV"

April 1, 2021

Decks in 2021